XLKG(000955)

Search documents
欣龙控股(000955) - 2023 Q2 - 季度财报(更正)
2024-04-29 11:18
Financial Performance - The company's operating revenue for the first half of 2023 was ¥261,894,669.92, a decrease of 31.02% compared to the same period last year[3]. - The net profit attributable to shareholders was a loss of ¥3,365,350.63, representing an improvement of 83.67% from a loss of ¥20,614,421.65 in the previous year[3]. - The net cash flow from operating activities was a negative ¥40,011,110.11, which is a decline of 116.87% compared to the previous year[4]. - The total assets at the end of the reporting period were ¥969,405,268.31, down 8.36% from the end of the previous year[4]. Industry Trends - The company reported a decrease in the production of non-woven fabrics by 2.23% in the first half of 2023, with revenue and profit from major enterprises in the industry declining by 5.02% and 65.98%, respectively[10]. Strategic Focus - The company aims to enhance market development, product management, customer service, and innovation as part of its strategic focus[11]. - The company has made progress in reducing losses in its main business despite a challenging economic environment[12]. Fund Management - The company recovered the entire investment principal of 30 million RMB from the Hongmian Fund[13]. - The Hongmian Fund received a payment of 18 million RMB from Hainan Zhuhua on May 29, 2023[13]. - Hainan Zhuhua committed to pay an additional 4,827,945 RMB and interest by September 30, 2023[13]. - The Hongmian Fund held a partner meeting on June 25, 2023, agreeing to proceed with formal liquidation[13]. - The company has actively promoted the completion of the fund's liquidation following the receipt of subsequent payments from Hainan Zhuhua[13].
欣龙控股:关于公司副总裁兼董事会秘书辞职的公告
2024-03-26 10:22
证券代码:000955 证券简称:欣龙控股 公告编号:2024-004 欣龙控股(集团)股份有限公司 关于公司副总裁兼董事会秘书辞职的公告 欣龙控股(集团)股份有限公司(以下简称"公司")董事会于 2024 年 3 月 26 日收到公司副总裁、董事会秘书李翔先生提交的辞职报告,李 翔先生因个人原因申请辞去公司副总裁、董事会秘书职务。根据《公司 法》《公司章程》等相关规定,其辞职报告自送达董事会时生效。李翔先 生辞去公司副总裁、董事会秘书职务后,不再担任公司其他职务。 截止本公告日,李翔先生未持有本公司股份。李翔先生承诺离任后 在规定期限内将继续遵循《上市公司股东、董监高减持股份的若干规定》 《深圳证券交易所上市公司股东及董事、监事、高级管理人员减持股份 实施细则》等相关规定进行管理。 李翔先生在担任公司副总裁、董事会秘书期间勤勉尽责、恪尽职守, 为公司的规范运作和经营发展做出了重要贡献,公司及公司董事会对其 表示衷心的感谢。 根据《深圳证券交易所股票上市规则》的有关规定,在未聘任新的 董事会秘书期间,公司董事会指定公司副总裁周菊锋先生代为履行董事 会秘书职责。公司董事会将按照相关规定尽快聘任新的董事会秘书。 ...
欣龙控股:第八届董事会第十二次会议决议公告
2024-03-26 10:22
欣龙控股(集团)股份有限公司 第八届董事会第十二次会议决议公告 证券代码:000955 证券简称:欣龙控股 公告编号:2024-003 本公司及董事会全体成员保证公告内容的真实、准确、完整,没有虚假记载、误 导性陈述或者重大遗漏。 欣龙控股(集团)股份有限公司(以下简称公司)第八届董事会第十 二次会议于2024年3月23日分别以专人送达、电子邮件、电话通知方式发 出会议通知,于2024年3月26日在海南省海口市美兰区国兴大道3号互联网 金融大厦B座23层一号会议室以现场加视频的形式召开。本次会议应参加 人数为8人,实际参加人数为8人。会议由董事长鲍钺先生主持。会议符合 《公司法》及《公司章程》的规定。会议以8票同意,0票反对,0票弃权, 审议并通过了《关于聘任公司高级管理人员的议案》,聘任周菊锋先生为 公司副总裁。 特此公告 欣龙控股(集团)股份有限公司 董 事 会 2024 年 3 月 26 日 附:周菊锋先生简历 1 2 周菊锋,男,1979年8月生,中国国籍,无境外永久居留权,中欧国 际工商学院FMBA,注册会计师。 工作经历:2011年11月至2024年3月在天堂硅谷创业投资集团有限公 司历任高级风控 ...
欣龙控股:关于公司董事逝世的讣告
2024-02-05 08:08
股票代码:000955 股票简称:欣龙控股 公告编号:2024-002 欣龙控股(集团)股份有限公司 郭开铸先生直接持有公司股份 354,700 股,持股比例 0.07%,其 所持的公司股份将按相关法律法规办理继承手续。 郭开铸先生去世后,公司现任董事会成员由 9 人减少至 8 人,未 低于《公司法》规定的董事会最低人数。公司将尽快完成董事补选等 工作,并及时履行信息披露义务。 目前,公司董事、监事及高级管理人员正常履职,公司各项经营 业务活动一切正常。公司董事、监事、高级管理人员及全体员工将继 续勤勉尽责,推动公司持续稳健发展。 关于公司董事逝世的讣告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导 性陈述或者重大遗漏。 欣龙控股(集团)股份有限公司(以下简称"公司")董事会沉 痛公告,公司董事郭开铸先生于 2024 年 2 月 4 日因病逝世。 郭开铸先生是公司创始人,为公司的创立和发展做出了卓越贡献。 公司董事、监事、高级管理人员及全体员工,对郭开铸先生为公司所 做的努力和贡献致以崇高敬意,对郭开铸先生去世表示沉痛哀悼和深 切缅怀,并向其家属表示深切慰问。 董 事 会 2 ...
欣龙控股:关于公司高级管理人员辞职的公告
2023-11-27 07:48
股票简称:欣龙控股 股票代码:000955 公告编码:2023-027 截至本公告披露日,钱军强先生未持有本公司股份。钱军强先生 承诺离任后在规定期限内将继续遵循《上市公司股东、董监高减持股 份的若干规定》《深圳证券交易所上市公司股东及董事、监事、高级 管理人员减持股份实施细则》等相关规定进行管理。 钱军强先生在公司任职副总裁期间认真履职、勤勉尽责,公司董 事会对钱军强先生在任职期间为公司发展所作出的贡献表示衷心的 感谢! 特此公告 欣龙控股(集团)股份有限公司 关于公司高级管理人员辞职的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,对公告的虚假记载、误 导性陈述或者重大遗漏负连带责任。 欣龙控股(集团)股份有限公司(以下简称"公司")董事会于 2023 年 11 月 24 日收到钱军强先生递交的书面辞职报告,钱军强先 生因个人原因申请辞去公司副总裁职务。钱军强先生辞去上述职务后, 将不再担任公司及公司子公司任何职务。 钱军强先生的辞职报告自送达公司董事会之日起生效。钱军强先 生的辞职不会影响公司的正常生产经营。 欣龙控股(集团)股份有限公司 董 事 会 2023 年 11 月 27 日 ...
欣龙控股:关于公司高级管理人员辞职的公告
2023-11-22 08:04
魏毅女士的辞职报告自送达公司董事会之日起生效。魏毅女士的 辞职不会影响公司的正常生产经营。 股票简称:欣龙控股 股票代码:000955 公告编码:2023-026 欣龙控股(集团)股份有限公司 关于公司高级管理人员辞职的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,对公告的虚假记载、误导 性陈述或者重大遗漏负连带责任。 欣龙控股(集团)股份有限公司(以下简称"公司")董事会于 2023 年 11 月 21 日收到魏毅女士递交的书面辞职报告,魏毅女士因 个人原因申请辞去公司执行总裁职务。魏毅女士辞去上述职务后,将 不再担任公司及公司子公司任何职务。 2023 年 11 月 22 日 截至本公告披露日,魏毅女士持有本公司股份 150,000 股。魏毅 女士承诺其所持公司股份在规定期限内将继续遵循《上市公司股东、 董监高减持股份的若干规定》《深圳证券交易所上市公司股东及董事、 监事、高级管理人员减持股份实施细则》等相关规定进行管理。 魏毅女士在公司任职期间恪尽职守、勤勉尽责,公司董事会对魏 毅女士在任职期间为公司健康稳定发展所作出的贡献表示衷心的感 谢! 特此公告 欣龙控股(集团)股份有限公司 董 事 ...
欣龙控股(000955) - 2023 Q3 - 季度财报
2023-10-30 16:00
欣龙控股(集团)股份有限公司 2023 年第三季度报告 证券代码:000955 证券简称:欣龙控股 公告编号:2023-025 欣龙控股(集团)股份有限公司 2023 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 是 □否 追溯调整或重述原因 会计政策变更 | | | 上年同期 | | 本报告 期比上 | | | | 年初至报 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | 上年同期 | | 告期末比 | | | | | | 年同期 | 年初至报 ...
欣龙控股:关于并购基金风险处理的进展公告
2023-10-24 07:56
欣龙控股(集团)股份有限公司 关于并购基金风险处理的进展公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 欣龙控股(集团)股份有限公司(以下简称"公司")于 2021 年 3 月 5 日披露了参与设立的深圳前海红棉基金健康产业投资中心(有 限合伙)(以下简称"红棉基金")的风险提示;后续又披露了相关的 进展公告,具体内容详见公司 2021 年 3 月 5 日披露的《关于并购基 金风险提示的公告》(公告编号:2021-005)和 2021 年 4 月 23 日、 2021 年 12 月 23 日、2022 年 9 月 1 日、2023 年 6 月 29 日披露的《关 于并购基金风险处理的进展公告》(公告编号:2021-009、2021-037、 2022-036、2023-019)。 2023 年 10 月 23 日,公司收到红棉基金管理人深圳市红棉资本 管理有限公司(以下简称"红棉资本")发来的专项报告,报告主要 内容如下: 一、关于海南筑华科工贸有限公司(以下简称"海南筑华")承担 连带担保责任案件的执行进展 根据 2023 年 6 月 9 日海南筑华向深圳 ...
欣龙控股(000955) - 2023 Q2 - 季度财报
2023-08-29 16:00
Financial Performance - The company's operating revenue for the first half of 2023 was ¥319,853,133.27, a decrease of 15.75% compared to the same period last year[20]. - The net profit attributable to shareholders was a loss of ¥3,365,350.63, an improvement of 83.67% from a loss of ¥20,614,421.65 in the previous year[20]. - The net cash flow from operating activities was a negative ¥40,011,110.11, representing a decline of 116.87% compared to the previous year[20]. - Total assets at the end of the reporting period were ¥969,405,268.31, down 8.36% from the end of the previous year[20]. - The company's revenue for the first half of 2023 was approximately ¥319.85 million, a decrease of 15.75% compared to ¥379.67 million in the same period last year[44]. - The operating costs also decreased by 16.04% to ¥296.88 million from ¥353.58 million, aligning with the drop in revenue[44]. - The company reported a significant reduction in losses for its main business compared to the previous year, despite a challenging economic environment[38]. - The company reported a net loss of CNY 338,308,830.76 for the first half of 2023, compared to a net loss of CNY 334,943,480.13 at the beginning of the year[144]. - The total comprehensive income for the first half of 2023 was CNY -5,584,181.70, compared to CNY -21,028,622.03 in the first half of 2022[151]. Business Operations - The company operates primarily in the non-woven fabric sector, with significant investments in production capacity[15]. - The company is engaged in three main business areas: non-woven new materials, pharmaceutical health and consumer products, and investment and trade[28]. - The non-woven new materials business includes the production of water-jet and melt-blown non-woven fabrics, with a focus on high-end differentiated products[28]. - The company has established itself as a supplier for several Fortune 500 companies in the high-end non-woven materials market[28]. - The company is focused on enhancing its core competitiveness in the textile and apparel industry[14]. - The company has a strong focus on R&D, continuously innovating to meet market demands and fill domestic gaps in high-end non-woven materials[29]. - The company has successfully developed new materials, including antibacterial hemp materials and biodegradable surgical gown materials, through its research and development center[32]. - The company is actively addressing historical inefficiencies and has made progress in recovering overdue receivables[37]. - The company’s medical health business is stable, focusing on leveraging quality pharmaceutical products and enhancing distribution channels[34]. Financial Management - The company reported non-recurring gains of ¥13,610,042.97, primarily from the disposal of non-current assets and government subsidies[24]. - The basic earnings per share improved to -¥0.0063, an increase of 83.55% from -¥0.0383 in the previous year[20]. - The company reported a significant reduction in sales expenses, totaling approximately ¥2.93 million, a decrease of 32.50% year-on-year, primarily due to lower performance bonuses resulting from decreased sales revenue[57]. - The company has implemented a low-risk operating model for its non-woven materials and OEM/ODM terminal consumer products, primarily through direct sales channels[54]. - The company has established long-term stable partnerships with upstream raw material suppliers and is actively seeking innovation and research collaboration opportunities[97]. Market Conditions - In the first half of 2023, the non-woven fabric industry in China experienced a decline, with production down by 2.23% year-on-year, and revenue and profit for large enterprises decreasing by 5.02% and 65.98% respectively[33]. - The company's main business faced continuous pressure, with efforts focused on market expansion, product management, customer service, and innovation to adapt to new trends and demands[37]. - The investment business is centered around equity investments aligned with the company's strategic direction, particularly in the context of Hainan Free Trade Port development[36]. - The consumer goods segment is leveraging non-woven material advantages to develop and sell mid-to-high-end health consumer products, although market demand remains weak[35]. Governance and Compliance - The financial report was confirmed to be true, accurate, and complete by the board of directors and management[3]. - There are no significant changes in the company's governance structure reported during the period[25]. - The company has maintained its commitment to environmental and social responsibilities[26]. - The company has established a new wastewater discharge permit valid from September 3, 2023, to September 2, 2028, ensuring compliance with environmental regulations[91]. - The company emphasizes the importance of ESG principles, having obtained ISO9001 and ISO14001 certifications, and aims to integrate these principles into its development strategy[95]. - The company has installed online monitoring facilities for environmental compliance and conducts regular third-party inspections[93]. Risks and Challenges - The company faces macroeconomic risks due to its reliance on the non-woven materials industry, which is closely tied to national economic conditions[78]. - Since 2021, the non-woven industry has seen a significant increase in production capacity, leading to intensified market competition amid weak global economic recovery[78]. - The company has implemented measures to monitor credit risk, including setting credit policies and evaluating customer creditworthiness based on financial status and market conditions[80]. - Liquidity risk is managed by continuously monitoring short-term and long-term funding needs to maintain sufficient cash reserves[81]. - The company has a substantial portion of its business in exports, primarily denominated in USD and EUR, making it vulnerable to foreign exchange risks[81]. Shareholder Information - The company reported a total of CNY 91,767.40 in other comprehensive income, which contributes to the overall equity position[170]. - The total equity attributable to the parent company's shareholders at the end of the reporting period was CNY 902,667,786.03, compared to CNY 813,883,261.76 at the end of the previous year, representing an increase of approximately 10.4%[166]. - The total stock capital remained stable at CNY 538,395,000.00, reflecting consistent shareholder investment[172]. - The total approved guarantee amount for subsidiaries during the reporting period was CNY 16,000 million, with actual occurrences totaling CNY 3,870 million[120]. - The company has no significant contracts or other major matters to disclose for the reporting period[123][124]. Future Outlook - The company aims to leverage the advantages of the Hainan Free Trade Port to enhance talent acquisition and develop new business growth points[42]. - The company plans to continue focusing on capital accumulation and strategic investments to enhance shareholder value in the future[169]. - The company is committed to enhancing its brand and market influence through innovative development paths in collaboration with its partners[35].
欣龙控股:独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
2023-08-29 08:11
一、截止 2023 年 6 月 30 日,公司累计对外担保额度为人民币 20,000 万元,实际担保金额为人民币 5,270 万元,占公司报告期末 净资产的 7.64%;公司对外担保均按规定提交董事会及股东大会审议 通过,并均取得董事会全体成员 2/3 以上签署同意。经我们核查确认, 未发现公司有为其控股股东及控股股东所属企业提供担保的情况。 欣龙控股(集团)股份有限公司 独立董事意见 作为欣龙控股(集团)股份有限公司(以下简称公司)第八届董 事会独立董事,何佳先生、张瑞君先生、高志勇先生就公司对外担保 情况、与关联方资金往来情况发表如下独立意见: 根据中国证监会《关于规范上市公司与关联方资金往来及上市公 司对外担保若干问题的通知》(证监发[2003] 56 号)的要求,作为 公司独立董事,我们对公司报告期内及累计对外担保情况和公司与关 联方资金往来情况进行了核查。经核查确认: 二、至本报告期末,未有关联方占用本公司资金的情况。 独立董事:何佳 张瑞君 高志勇 2023 年 8 月 28 日 ...